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Abstract. Resistance of the malaria parasite to conventional therapeutic agents calls for increased efforts in antimalarial 
drug discovery. Current efforts should be targeted at developing safe and affordable new agents to counter the spread of 
malaria parasites that are resistant to existing therapy. In this study, toxicological and in vivo antiplasmodial properties of 
3-(5-(s-phenyl)-4H-pyrazol-3-yl)-42H-chromen-2, Mangifera indica and Tithonia diversifolia in swiss albino mice 
models, Musmusculus were investigated. 2H-Chromen-2-one also known as coumarin is highly privileged oxygen-
containing heterocyclic entity which are present in plant kingdom as secondary metabolites. The maceration technique of 
crude drug extraction was employed using cold water extraction. Toxicological analysis was carried out using Lorke’s 
method for acute toxicity testing while the chemosuppressive activity was carried out using Peter’s four day test on early 
infection. We also report the synthesis of functionalized 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-chromen-2-one motifs via 
microwave assisted synthetic approach and isolation of indigenous plant extract in order to investigate their antimalarial 
efficacy. The condensation reaction of 3-acetylcoumarin with various benzaldehyde derivatives resulted in the formation 
of 3-[3-acryloyl]-2H-chromen-2-one which was subsequently reaction the hydrazine hydrate via microwave assisted 
hydrazinolysis to afford the targeted 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-chromen-2-one motifs. The chemical structures 
were confirmed by analytical data and spectroscopic means such as FT-IR, UV, 1H NMR, 13C NMR and DEPT-135. The 
microwave assisted reaction was remarkably successful and gave targeted 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-chromen-
2-one motifs in higher yields at lesser reaction time compared to conventional heating method. The LD50 of the aqueous 
extracts of the leaves and stem bark Mangifera indica was established to be ± 707.11 mg/kg b.w., p.o. (body weight, 
administered orally) in mice. Tithonia diversifolia aqueous leaf extracts is non-toxic at doses as high as 1000 mg/kg while 
the LD50 of the ethanolic leaf extracts was established to be ± 707.11 mg/kg b.w., p.o. in mice. The in vivo antiplasmodial 
activity was studied in chloroquine-sensitive Plasmodium berghei berghei - NK65 infected mice. All the plant extracts, at 
the doses (100, 200 and 400 mg/kg b.w., p.o.) used, produced significant (p < 0.05), dose dependent activity (> 80% 
inhibition of parasitaemia at maximum dose) against the parasite in the suppressive tests. The in vitro antimalarial 
screening of the synthesized compounds is presently on-going and the finding will be reported in due course. 
INTRODUCTION 
Malaria is a leading cause of death globally. Although this past year has recorded some success in the fight 
against the disease, malaria still continues to take its toll in the WHO African Region with over 88% of reported 
cases occurring in this region [1]. A major challenge encountered in the control of malaria today is antimalarial drug 
resistance. This has resulted in the spread of malaria to new areas and re-emergence of malaria in areas where the 
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disease had been eradicated [2]. In 2015, malaria was the fourth leading cause of death, accounting for 10% of child 
deaths in sub-Saharan Africa [1]. For several generations, plants have served as a source of various kinds of 
remedies for medicinal purposes to treat different types of ailments. They are still being used as remedies especially 
in rural areas in developing countries. In most parts of sub-Saharan Africa, traditional medicine has been acclaimed 
to be vital in preventing and curing various diseases, thereby playing an important role in health and well-being [3]. 
In tandem with the rising increase in antimalarial drug resistance, experimental research should be carried out on the 
rich biodiversity of natural flora that could possibly translate to meaningful drug discovery and synthesis of 
important pharmacologically active antimalarial compounds. New antimalarial drugs are expected to exhibit rapid 
efficacy, minimal toxicity and low cost. 
MATERIALS AND METHODS 
Functionalized 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-chromen-2-one motifs was synthesized via microwave 
assisted synthetic approach. Ethanolic Extraction Procedure for Tithonia diversifolia and Mangifera indica was 
carried out as described by Olasehinde et al. [4]. Antiplasmodial activities of synthesized drug candidate and plant 
extracts were examined using the 4-day Peter’s test method. Swiss albino mice, Mus musculus of either sex 
weighing between 18-25g of either sex were obtained from the Nigerian Institute of Medical Research (NIMR). 
Ethical approval was obtained from the Covenant University Research Ethics Committee (CUREC).The 
Plasmodium berghei berghei NK65 rodent parasite used to assess the antimalarial potential of the extracts was 
obtained from National Institute for Medical Research (NIMR), Lagos, Nigeria. Parasite inoculation was carried out 
according to standard methods. Acute assessment of toxicity was performed to determine the lethality and potency 
of the extracts. In order to determine LD50 (Lethal Dose 50), the acute toxicity of the crude extracts of the plant 
material was evaluated using the Lorke’s method [5] with a slight modification. The chemo-suppressive activity of 
the aqueous extracts of the plant material was assessed by the 4-day suppressive test of acute infection developed by 
[6]. Percentage chemo-suppression is taken as inhibition of parasite growth/multiplication by the extract relative to 
the control expressed in percentage. 
 
 Percentage chemo-suppression= 
(A-B)
A
×100 (1) 
 
Where A is the average parasitaemia in the negative control group, B is the average parasitaemia in the test 
group. 
 
 That is 
(control mean-dose mean)
control mean
 ×100 (2) 
 
The means were calculated as mean ± standard error of mean. 
Statistical Analysis 
Results obtained were expressed as mean ± standard error of mean (S.E.M.). The significance of difference 
between the controls and treated groups was determined using the student t-test one way analysis of variance 
(ANOVA) at p < 0.05 were considered to be statistically significant. The results were analysed using IBM SPSS 
22.0. 
RESULTS AND DISCUSSION 
The microwave assisted reaction was remarkably successful and gave targeted 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-
2H-chromen-2-one motifs in higher yields at lesser reaction time compared to conventional heating method. The 
strategic synthesis of the targeted pyrazole-based coumarin motifs was successful. Microwave assisted synthesis was 
more efficient and ecofriendly as compared with conventional heating method under reflux and the targeted 
compounds are good candidates for further study for effective future drug design (Figure 1 and Figure 2). The 
microwave assisted reaction was remarkably successful and gave targeted 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-
chromen-2-one motifs in higher yields at lesser reaction time compared to conventional heating method (Table 1). 
The strategic synthesis of the targeted pyrazole-based coumarin motifswas successful. microwave assisted Synthesis 
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was more efficient and ecofriendly as compared with conventional heating method under reflux and the targeted 
compounds are good candidates for further study for effective future drug design. The LD50 of the aqueous extracts 
of the leaves and stem bark Mangifera indica was established to be ± 707.11 mg/kg b.w., p.o. (body weight, 
administered orally) in mice. Tithonia diversifolia aqueous leaf extracts is non-toxic at doses as high as 1000 mg/kg 
while the LD50 of the ethanolic leaf extracts was established to be ± 707.11 mg/kg b.w., p.o. in mice. The in vivo 
antiplasmodial activity was studied in chloroquine-sensitive Plasmodium berghei berghei -NK65 infected mice. All 
the plant extracts, at the doses (100, 200 and 400 mg/kg b.w., p.o.) used, produced significant (p < 0.05), dose 
dependent activity (> 80% inhibition of parasitaemia at maximum dose) against the parasite in the suppressive tests. 
The antiplasmodial activity of synthesized 3-(5-(s-phenyl)-4H-pyrazol-3-yl)-2H-chromen-2-one motifs will be 
reported. 
TABLE 1. Result of physico-chemical properties of the products 3a-h 
Com 
No 
Molecular 
formula 
Mol. Wt. 
Melting Pt 
(oC) 
Colour 
Elem. Analysis: %Cald (%Found) 
C H N 
3a C18H14O2N2 290 111 Orange 74.48 (74.61) 4.83 (5.01) 9.66 (9.75) 
3b C20H19O2N3 333 152-154 Orange 72.07 (71.96) 5.71 (5.87) 
12.61 
(12.80) 
3c C17H16O4N2 311 143-145 Orange 69.15 (69.29) 5.42 (5.33) 9.49 (9.59) 
3d C20H17O3N2 333 120-121 Yellow 72.07 (71.88) 5.11 (4.98) 8.41 (8.56) 
3e C18H13O2N2Cl 322 150-153 Yellow 67.08 (66.81) 4.04 (3.97) 8.70 (8.61) 
3f C18H14O3N2 306 129-131 Brown 70.59 (70.42) 4.58 (4.44) 9.15 (9.29) 
3g C18H14O3N2 306 140-141 Orange 
70.59 
(70.49) 
4.58 (4.43) 9.15 (9.08) 
3h C19H14O3N2 295 120-121 Orange 
69.15 
(69.05) 
5.08 (4.98) 9.49 (9.69) 
TABLE 2. Percentage chemo-suppression of the aqueous extracts of Mangifera indica leaves 
Drug Dose Mean Parasitaemia density 
(D3) 
Percentage chemo suppression 
(%) 
Physiological saline 0.5 ml 334.00±10.00 0 
M. indica 100 mg/kg 113.75±7.78 65.94* 
Leaves 200 mg/kg 104.33±6.34 68.76* 
 400 mg/kg 50.25±5.45 84.95* 
Chloroquine phosphate 10 mg/kg 5.50±1.32 98.35* 
D3= Day 4, *significantly different from negative control at p < 0.05 (n=4) 
TABLE 3. Percentage chemo-suppression of the aqueous extracts of Mangifera indica bark 
Drug Dose Mean Parasitaemia density 
(D3) 
Percentage chemo suppression 
(%) 
Physiological saline 0.5 ml 359±4.50  
M. indica 100 mg/kg 110.20±4.56 69.30* 
Bark 200 mg/kg 92.75±4.63 74.16* 
 400 mg/kg 71.0±4.49 80.22* 
Chloroquine phosphate 10 mg/kg 9.00±1.55 97.49* 
D3= Day 4, *significantly different from negative control at p < 0.05 (n=4) 
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TABLE 4. Percentage chemo-suppression of the aqueous extracts of T. diversifolia leaves 
Drug Dose Mean Parasitaemia density 
(D3) 
Percentage chemo suppression 
(%) 
Physiological saline 0.5 ml 359±4.50 - 
T. diversifolia 100 mg/kg 96.33±17.95 73.54* 
Leaves 200 mg/kg 78.67±13.84 78.39* 
 400 mg/kg 48.25±9.67 86.74* 
Chloroquine phosphate 10 mg/kg 10.00±1.29 97.25* 
D3= Day 4, *significantly different from negative control at p < 0.05 (n=4) 
TABLE 5. Percentage chemo-suppression of the ethanolic extracts of T. diversifolia leaves 
Drug Dose Mean Parasitaemia density 
(D3) 
Percentage chemo suppression 
(%) 
Physiological saline 0.5 ml 334±10.00 - 
T. diversifolia 100 mg/kg 83.00±9.51 75.15* 
Leaves 200 mg/kg 60.00±6.47 82.04* 
 400 mg/kg 48.50±9.06 85.48* 
Chloroquine phosphate 10 mg/kg 2.75±1.80 99.40* 
D3= Day 4, *significantly different from negative control at p < 0.05 (n=4) 
 
FIGURE 1. Synthetic pathway to (a) precursor and (b) Pyrazole-based coumarin products 3a-h 
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 FIGURE 2. a) 13C-NMR and b) DEPT-135 Spectrum of 3a 
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 FIGURE 3. Graphical representation of rate of parasitaemia n aqueous extracts of M. indica leaves 
 
 
FIGURE 4. Graphical representation of the trend in the burden of parasitaemia for the aqueous extracts of M. indica stem bark 
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 FIGURE 5. Graphical representation of the trend in the burden of parasitaemia for the aqueous extracts of T. diversifolia leaves 
 
 
FIGURE 6. Graphical representation of the trend in the burden of parasitaemia for the ethanolic extracts of T. diversifolia leaves 
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